Genentech: Baris Bingol

Por um escritor misterioso
Last updated 22 dezembro 2024
Genentech: Baris Bingol
I am proud to be part of the scientific team at Genentech that values scientific excellence above all to fuel therapeutic programs for patients in need.
Genentech: Baris Bingol
Baris BINGOL, Genentech, California, Department of Neuroscience
Genentech: Baris Bingol
Multiclass semantic segmentation mediated neuropathological readout in Parkinson's disease - ScienceDirect
Genentech: Baris Bingol
Baris BINGOL, Genentech, California, Department of Neuroscience
Genentech: Baris Bingol
PPEF2 Opposes PINK1-Mediated Mitochondrial Quality Control by Dephosphorylating Ubiquitin - ScienceDirect
Genentech: Baris Bingol
Genentech: Baris Bingol
Genentech: Baris Bingol
Genentech: Casper Hoogenraad VP Neuroscience, Neuroscience
Genentech: Baris Bingol
From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors
Genentech: Baris Bingol
Global and Regional Changes in Perivascular Space in Idiopathic and Familial Parkinson's Disease - Donahue - 2021 - Movement Disorders - Wiley Online Library
Genentech: Baris Bingol
The mitochondrial deubiquitinase USP30 opposes parkin--ediated mitophagy - Document - Gale OneFile: Health and Medicine
Genentech: Baris Bingol
Gail D Lewis - Senior Principal Scientist - Genentech
Genentech: Baris Bingol
Bay Area Molecular Neuroscience Meeting – July 20th, 2018 – UC Berkeley
Genentech: Baris Bingol
Genentech: Eric Brown Vice President, Translational Biology
Genentech: Baris Bingol
Ocular phenotypes in a mouse model of impaired glucocerebrosidase activity

© 2014-2024 praharacademy.in. All rights reserved.